For: | Zhao BW, Chen YJ, Zhang RP, Chen YM, Huang BW. Angiotensin-converting enzyme 2 alleviates liver fibrosis through the renin-angiotensin system. World J Gastroenterol 2024; 30(6): 607-609 [PMID: 38463024 DOI: 10.3748/wjg.v30.i6.607] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v30/i6/607.htm |
Number | Citing Articles |
1 |
Michele Barone. Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?. World Journal of Gastroenterology 2024; 30(18): 2391-2396 doi: 10.3748/wjg.v30.i18.2391
|
2 |
Xóchitl Andrea Mendiola-Salazar, Melanie A. Munguía-Laguna, Martha Franco, Agustina Cano-Martínez, José Santamaría Sosa, Rocío Bautista-Pérez. SARS-CoV-2 Spike Protein Enhances Carboxypeptidase Activity of Angiotensin-Converting Enzyme 2. International Journal of Molecular Sciences 2024; 25(11): 6276 doi: 10.3390/ijms25116276
|
3 |
Wei Dai, Yuan-Qi Li, You Zhou. Clinical implications of the latest advances in gastrointestinal tumor research. World Journal of Gastrointestinal Oncology 2024; 16(10): 4055-4059 doi: 10.4251/wjgo.v16.i10.4055
|